Mellow Hope granted H1N1 license by SFDA

NewsGuard 100/100 Score

HTDS- The issuer's China based operating subsidiary Mellow Hope through its exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd has been granted H1N1 license on September 24, 2009 by SFDA (China Authority) http://eng.sfda.gov.cn/eng. Mellow Hope is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales.

Today, the issuer completed a set of filings in both Chinese and English translations on Pink Sheets www.pinksheets.com see filing titled "Supplemental Information - H1N1 License and Supporting Documents" or this direct link.

The company believes that there is a naked short interest in the stock and the company has retained counsel to investigate this matter and possible market manipulation by short sellers. In this connection, the Company has received numerous allegations and complaints from shareholders. In addition, the company has been the victim of anonymous "stock bashing" and a campaign of negative publicity, a smear campaign. In fact, there is a lawsuit in progress on some of these issues.

"We believe that the full potential of our H1N1 vaccine business has yet to be realized in our stock price and this report outlines some of the issues involved," said HTDS CEO Terry Yuan. "Take a good look at all that is going on now for HTDS and you may be surprised to find that when you do so, you share our enthusiasm for HTDS. H1N1 is done and completed so we are eager to start to profit from this huge demand from customers who want to now buy HTDS products immediately. We are also moving with great energy to get our audits completed and get OTCBB listed. When you look at the potential cancer and anti-aging projects of Slavica Bio Chem it is easy to find yourself strongly visualizing their enormous potential. HTDS is also taking aggressive action against the suspected naked shorting that has apparently affected our stock so we can remove all possible barriers to appreciation and give our investors confidence in the future of their investment.

Further, most people do not seem to realize we have recently made a sizable recent reduction in our stock outstanding and understand fully what that means. When you add all the excitement all this has created to our eagerness to move forward, it can cause you to start to see that we are on verge of a major expansion. We believe you have to find yourself putting HTDS in that spot in your mind where you would put a company that has virtually unlimited upside. We look forward to the future and we believe that a year from now we will find ourselves looking back on back on this time as one where we all participated in a major expansion."

Source:

Hard to Treat Diseases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LabVantage celebrates customer success with record number of software deployments in FY 2024